DUBLIN--(BUSINESS WIRE)--The "Fertility Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Fertility Testing Market to Reach $644.7 Million by 2027

Amid the COVID-19 crisis, the global market for Fertility Testing estimated at US$428.5 Million in the year 2020, is projected to reach a revised size of US$644.7 Million by 2027, growing at a CAGR of 6% over the analysis period 2020-2027.

Ovulation Predictor Kits, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$275.7 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fertility Monitors segment is readjusted to a revised 5.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $116 Million, While China is Forecast to Grow at 9.2% CAGR

The Fertility Testing market in the U.S. is estimated at US$116 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$137.5 Million by the year 2027 trailing a CAGR of 9.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 5.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Male Fertility Testing Products Segment to Record 6% CAGR

In the global Male Fertility Testing Products segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$70.7 Million in the year 2020 will reach a projected size of US$102.7 Million by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$87 Million by the year 2027, while Latin America will expand at a 7.2% CAGR through the analysis period.

Select Competitors (Total 41 Featured):

• AdvaCare Pharma
• Ava Science Inc.
• Babystart
• bioZhena Corporation
• Church & Dwight Co., Inc.
• Fairhaven Health LLC
• Fertility Focus Ltd
• Geratherm Medical AG
• Hilin Life Products
• Prestige Brands Holdings, Inc.
• Sensiia
• SPD Swiss Precision Diagnostics GmbH
• TaiDoc Technology Corporation
• UEBE Medical GmbH
• Valley Electronics AG

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• Influencer Market Insights
• Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

IV. COMPETITION

• Total Companies Profiled: 41

For more information about this report visit https://www.researchandmarkets.com/r/gy853v.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900